[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100053702":3},{"organization":4,"outcomesModule":7,"designInfo":24,"detailedDescription":11,"studyPopulation":11,"armGroups":31,"interventions":65,"overallOfficials":71,"centralContacts":76,"locations":85,"responsibleParty":283,"collaborators":11,"id":285,"slug":286,"hasResults":287,"nctId":288,"briefTitle":289,"officialTitle":290,"acronym":11,"eligibilityCriteria":291,"healthyVolunteers":287,"sex":292,"minAge":293,"maxAge":294,"enrollmentInfo":295,"targetDuration":11,"studyType":298,"phases":299,"briefSummary":301,"conditions":302,"keywords":305,"overallStatus":88,"whyStopped":11,"lastUpdateSubmitDate":312,"lastUpdatePostDateStruct":313,"startDateStruct":316,"completionDateStruct":318,"leadSponsor":320,"locationsCount":321},{"fullName":5,"class":6},"Verve Therapeutics, Inc.","INDUSTRY",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":11},[9],{"measure":10,"description":11,"timeFrame":12},"Incidence of treatment-emergent adverse events (TEAEs) and serious adverse events (SAEs)",null,"up to Day 365",[14,16,18,20,22],{"measure":15,"description":11,"timeFrame":12},"Evaluation of maximum observed concentration (Cmax)",{"measure":17,"description":11,"timeFrame":12},"Evaluation of time to maximum observed concentration (tmax)",{"measure":19,"description":11,"timeFrame":12},"Evaluation of terminal elimination half-life (t1\u002F2)",{"measure":21,"description":11,"timeFrame":12},"Percent and absolute change from baseline in plasma PCSK9 concentration",{"measure":23,"description":11,"timeFrame":12},"Percent and absolute change from baseline in LDL-C",{"allocation":25,"interventionModel":26,"interventionModelDescription":27,"primaryPurpose":28,"observationalModel":11,"timePerspective":11,"maskingInfo":29},"NON_RANDOMIZED","SEQUENTIAL","Single ascending dose escalation\u002Fadaptive design.","TREATMENT",{"masking":30,"maskingDescription":11,"whoMasked":11},"NONE",[32,38,41,44,47,50,53,56,59,62],{"label":33,"type":34,"description":35,"interventionNames":36},"Cohort 1: Single Ascending Dose Escalation","EXPERIMENTAL","Participants will receive a single dose of VERVE-102.",[37],"Drug: VERVE-102",{"label":39,"type":34,"description":35,"interventionNames":40},"Cohort 2: Single Ascending Dose Escalation",[37],{"label":42,"type":34,"description":35,"interventionNames":43},"Cohort 3: Single Ascending Dose Escalation",[37],{"label":45,"type":34,"description":35,"interventionNames":46},"Cohort 4: Single Ascending Dose Escalation",[37],{"label":48,"type":34,"description":35,"interventionNames":49},"Cohort 5: Single Ascending Dose Escalation",[37],{"label":51,"type":34,"description":35,"interventionNames":52},"Cohort 6: Single Ascending Dose Escalation",[37],{"label":54,"type":34,"description":35,"interventionNames":55},"Cohort 7: Single Ascending Dose Escalation",[37],{"label":57,"type":34,"description":35,"interventionNames":58},"Cohort 8: Single Ascending Dose Escalation",[37],{"label":60,"type":34,"description":35,"interventionNames":61},"Cohort 9: Single Fixed Dose",[37],{"label":63,"type":34,"description":35,"interventionNames":64},"Cohort 10: Single Fixed Dose",[37],[66],{"type":67,"name":68,"description":69,"armGroupLabels":70,"otherNames":11},"DRUG","VERVE-102","Intravenous (IV) infusion",[63,33,39,42,45,48,51,54,57,60],[72],{"name":73,"affiliation":74,"role":75},"Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC\u002FGMT - 5 hours, EST)","Eli Lilly and Company","STUDY_DIRECTOR",[77,82],{"name":78,"role":79,"phone":80,"phoneExt":11,"email":81},"Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or","CONTACT","317-615-4559","LillyTrials@Lilly.com",{"name":83,"role":79,"phone":11,"phoneExt":11,"email":84},"Physicians interested in becoming principal investigators please contact","clinical_inquiry_hub@lilly.com",[86,100,109,118,126,134,143,152,161,170,177,184,193,200,207,214,221,228,237,246,255,262,269,276],{"facility":87,"status":88,"city":89,"state":90,"zip":91,"country":92,"countryCode":93,"cosmosGeoPoint":94,"geoPoint":99,"contacts":11},"Clinical Study Center","RECRUITING","Dothan","Alabama","36305","United States","US",{"type":95,"coordinates":96},"Point",[97,98],-85.39049,31.22323,{"lat":98,"lon":97},{"facility":87,"status":88,"city":101,"state":102,"zip":103,"country":92,"countryCode":93,"cosmosGeoPoint":104,"geoPoint":108,"contacts":11},"Pomona","California","91768",{"type":95,"coordinates":105},[106,107],-117.75228,34.05529,{"lat":107,"lon":106},{"facility":87,"status":88,"city":110,"state":111,"zip":112,"country":92,"countryCode":93,"cosmosGeoPoint":113,"geoPoint":117,"contacts":11},"Boca Raton","Florida","33434",{"type":95,"coordinates":114},[115,116],-80.0831,26.35869,{"lat":116,"lon":115},{"facility":87,"status":88,"city":119,"state":111,"zip":120,"country":92,"countryCode":93,"cosmosGeoPoint":121,"geoPoint":125,"contacts":11},"Jacksonville","32216",{"type":95,"coordinates":122},[123,124],-81.65565,30.33218,{"lat":124,"lon":123},{"facility":87,"status":88,"city":127,"state":111,"zip":128,"country":92,"countryCode":93,"cosmosGeoPoint":129,"geoPoint":133,"contacts":11},"Winter Park","32789",{"type":95,"coordinates":130},[131,132],-81.33924,28.6,{"lat":132,"lon":131},{"facility":87,"status":88,"city":135,"state":136,"zip":137,"country":92,"countryCode":93,"cosmosGeoPoint":138,"geoPoint":142,"contacts":11},"High Point","North Carolina","27260",{"type":95,"coordinates":139},[140,141],-80.00532,35.95569,{"lat":141,"lon":140},{"facility":87,"status":88,"city":144,"state":145,"zip":146,"country":92,"countryCode":93,"cosmosGeoPoint":147,"geoPoint":151,"contacts":11},"DeSoto","Texas","75115",{"type":95,"coordinates":148},[149,150],-96.85695,32.58986,{"lat":150,"lon":149},{"facility":87,"status":88,"city":153,"state":154,"zip":155,"country":92,"countryCode":93,"cosmosGeoPoint":156,"geoPoint":160,"contacts":11},"Renton","Washington","98057",{"type":95,"coordinates":157},[158,159],-122.21707,47.48288,{"lat":159,"lon":158},{"facility":87,"status":88,"city":162,"state":11,"zip":11,"country":163,"countryCode":164,"cosmosGeoPoint":165,"geoPoint":169,"contacts":11},"Adelaide","Australia","AU",{"type":95,"coordinates":166},[167,168],138.59863,-34.92866,{"lat":168,"lon":167},{"facility":87,"status":88,"city":171,"state":11,"zip":11,"country":163,"countryCode":164,"cosmosGeoPoint":172,"geoPoint":176,"contacts":11},"Melbourne",{"type":95,"coordinates":173},[174,175],144.96332,-37.814,{"lat":175,"lon":174},{"facility":87,"status":88,"city":178,"state":11,"zip":11,"country":163,"countryCode":164,"cosmosGeoPoint":179,"geoPoint":183,"contacts":11},"Sydney",{"type":95,"coordinates":180},[181,182],151.20732,-33.86785,{"lat":182,"lon":181},{"facility":87,"status":88,"city":185,"state":11,"zip":11,"country":186,"countryCode":187,"cosmosGeoPoint":188,"geoPoint":192,"contacts":11},"Chicoutimi","Canada","CA",{"type":95,"coordinates":189},[190,191],-71.06369,48.41963,{"lat":191,"lon":190},{"facility":87,"status":88,"city":194,"state":11,"zip":11,"country":186,"countryCode":187,"cosmosGeoPoint":195,"geoPoint":199,"contacts":11},"Hamilton",{"type":95,"coordinates":196},[197,198],-79.84963,43.25011,{"lat":198,"lon":197},{"facility":87,"status":88,"city":201,"state":11,"zip":11,"country":186,"countryCode":187,"cosmosGeoPoint":202,"geoPoint":206,"contacts":11},"Montreal",{"type":95,"coordinates":203},[204,205],-73.58781,45.50884,{"lat":205,"lon":204},{"facility":87,"status":88,"city":208,"state":11,"zip":11,"country":186,"countryCode":187,"cosmosGeoPoint":209,"geoPoint":213,"contacts":11},"Québec",{"type":95,"coordinates":210},[211,212],-71.21454,46.81228,{"lat":212,"lon":211},{"facility":87,"status":88,"city":215,"state":11,"zip":11,"country":186,"countryCode":187,"cosmosGeoPoint":216,"geoPoint":220,"contacts":11},"Toronto",{"type":95,"coordinates":217},[218,219],-79.39864,43.70643,{"lat":219,"lon":218},{"facility":87,"status":88,"city":222,"state":11,"zip":11,"country":186,"countryCode":187,"cosmosGeoPoint":223,"geoPoint":227,"contacts":11},"Vancouver",{"type":95,"coordinates":224},[225,226],-123.11934,49.24966,{"lat":226,"lon":225},{"facility":87,"status":88,"city":229,"state":11,"zip":11,"country":230,"countryCode":231,"cosmosGeoPoint":232,"geoPoint":236,"contacts":11},"Rehovot","Israel","IL",{"type":95,"coordinates":233},[234,235],34.81199,31.89421,{"lat":235,"lon":234},{"facility":87,"status":88,"city":238,"state":11,"zip":11,"country":239,"countryCode":240,"cosmosGeoPoint":241,"geoPoint":245,"contacts":11},"Christchurch","New Zealand","NZ",{"type":95,"coordinates":242},[243,244],172.63333,-43.53333,{"lat":244,"lon":243},{"facility":87,"status":88,"city":247,"state":11,"zip":11,"country":248,"countryCode":249,"cosmosGeoPoint":250,"geoPoint":254,"contacts":11},"Birmingham","United Kingdom","UK",{"type":95,"coordinates":251},[252,253],-1.89983,52.48142,{"lat":253,"lon":252},{"facility":87,"status":88,"city":256,"state":11,"zip":11,"country":248,"countryCode":249,"cosmosGeoPoint":257,"geoPoint":261,"contacts":11},"Edinburgh",{"type":95,"coordinates":258},[259,260],-3.19648,55.95206,{"lat":260,"lon":259},{"facility":87,"status":88,"city":263,"state":11,"zip":11,"country":248,"countryCode":249,"cosmosGeoPoint":264,"geoPoint":268,"contacts":11},"London",{"type":95,"coordinates":265},[266,267],-0.12574,51.50853,{"lat":267,"lon":266},{"facility":87,"status":88,"city":270,"state":11,"zip":11,"country":248,"countryCode":249,"cosmosGeoPoint":271,"geoPoint":275,"contacts":11},"Manchester",{"type":95,"coordinates":272},[273,274],-2.23743,53.48095,{"lat":274,"lon":273},{"facility":87,"status":88,"city":277,"state":11,"zip":11,"country":248,"countryCode":249,"cosmosGeoPoint":278,"geoPoint":282,"contacts":11},"Nottingham",{"type":95,"coordinates":279},[280,281],-1.15047,52.9536,{"lat":281,"lon":280},{"type":284,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100053702","phase-1-a-study-of-verve-102-in-patients-with-familial-hypercholesterolemia-or-premature-coronary-artery-disease-100053702",false,"NCT06164730","A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease","Open-label, Phase 1b, Single Ascending Dose Study to Evaluate the Safety of VERVE-102 Administered to Patients With Heterozygous Familial Hypercholesterolemia or Premature Coronary Artery Disease Who Require Additional Lowering of Low-density Lipoprotein Cholesterol","Inclusion Criteria:\n\n* Diagnosis of HeFH or premature CAD\n\nExclusion Criteria:\n\n* Homozygous familial hypercholesterolemia\n* Active or history of chronic liver disease\n* Current treatment with PCSK9 inhibitor or prior treatment within specified timeframe\n* Clinically significant or abnormal laboratory values as defined by the protocol","ALL","18 Years","70 Years",{"count":296,"type":297},85,"ESTIMATED","INTERVENTIONAL",[300],"PHASE1","VT-10201 is an Open-label, Phase 1b, Single-ascending Dose Study That Will Evaluate the Safety of VERVE-102 Administered to Patients With Heterozygous Familial Hypercholesterolemia (HeFH) or Premature Coronary Artery Disease (CAD) Who Require Additional Lowering of LDL-C. VERVE-102 Uses Base-editing Technology Designed to Disrupt the Expression of the PCSK9 Gene in the Liver and Lower Circulating PCSK9 and LDL-C. This Study is Designed to Determine the Safety and Pharmacodynamic Profile of VERVE-102 in This Patient Population.",[303,304],"Heterozygous Familial Hypercholesterolemia","Premature Coronary Heart Disease",[68,306,307,308,309,310,311],"Familial Hypercholesterolemia","Coronary Artery Disease","Dose Escalation","Gene Editing","Base Editing","heart-2","2026-07-10",{"date":314,"type":315},"2026-07-13","ACTUAL",{"date":317,"type":315},"2024-04-30",{"date":319,"type":297},"2027-08",{"name":5,"class":6},24]